Brii Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Brii Biosciences has a total shareholder equity of CN¥3.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.2B and CN¥111.6M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | n/a |
Cash | CN¥2.74b |
Equity | CN¥3.09b |
Total liabilities | CN¥111.58m |
Total assets | CN¥3.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2137's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥111.6M).
Long Term Liabilities: 2137 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 2137 is debt free.
Reducing Debt: 2137 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2137 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2137 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 18.7% each year